As of 2015, the MHRA has imposed stricter policies on the pharmaceutical industry to be more proactive in its efforts at data integrity. Data integrity is a fundamental component in a quality pharmaceutical system, ensuring that medicines are safe and effective. To satisfy the changes to MHRA regulatory requirements, pharmaceutical companies must continuously improve to create a culture of quality. Click here to read a white paper from Broughton Software on how businesses can implement a culture of quality for data integrity.
